Yarrowia Lipolytica GPI7 Deletion for Heterologous Protein Secretion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a single factor to effectively improve the production of heterologous proteins in Yarrowia lipolytica, necessitating the identification of improved large-scale expression systems for extracellular secretion.
Innovation Solution
Genetically modifying Yarrowia lipolytica cells by deleting the gpi7 gene to enhance the secretion of heterologous proteins into the extracellular space, resulting in increased levels of secretion compared to control populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the GPI biosynthetic pathway is intact, then cell wall structure and growth are maintained, but heterologous protein secretion is limited
Solution Approach 1:
The patent applies the extraction principle by deleting the GPI7 gene from the Yarrowia lipolytica genome, removing a specific component of the GPI biosynthetic pathway. This extraction allows heterologous proteins to be secreted extracellularly at elevated levels (at least twice that of control strains) while the remaining GPI pathway components maintain sufficient cell wall integrity for viable growth.
2Strength
If GPI proteins are integrated into the cell wall, then cell wall strength is improved, but extracellular protein secretion is reduced
Solution Approach 1:
The patent applies local quality by creating a selective deficiency in the GPI7 component while maintaining other GPI pathway functions. This localized modification allows the cell wall to retain sufficient strength through alternative GPI proteins and cell wall components, while simultaneously enabling enhanced extracellular secretion of heterologous proteins that would otherwise be retained intracellularly.
3Device complexity
If a single genetic modification is made, then the secretion mechanism is simplified, but the ability to maintain cell viability is reduced
Solution Approach 1:
The patent applies parameter changes by modifying the genetic parameter (GPI7 gene presence/absence) to achieve a desired phenotypic outcome (enhanced protein secretion). The single gene deletion represents a discrete parameter change that simplifies the genetic architecture while the organism's metabolic and regulatory networks compensate to maintain cell viability and growth.
Data Source
AI summary
This invention relates to protein and/or polypeptide production, particularly improved production of extracellular heterologous polypeptides and proteins. In particular, the invention relates to compositions of cell populations capable of improved levels of extracellular secretion relative to control populations, kits containing such compositions, methods of producing heterologous proteins of interest and recombinant microorganisms capable of improved extracellular heterologous protein production.